Desvenlafaxine
NDC 51991-312, Desvenlafaxine Succinate, tablet, extended release, from Breckenridge Pharmaceutical, Inc.
- Product NDC
- 51991-312
- Status
- Listed
- Labeler
- Breckenridge Pharmaceutical, Inc
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204003
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51991-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DESVENLAFAXINE SUCCINATE100 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51991-312-01 | 51991031201 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-01) |
| 51991-312-10 | 51991031210 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-10) |
| 51991-312-11 | 51991031211 | 100 TABLET, EXTENDED RELEASE in 1 CARTON (51991-312-11) |
| 51991-312-14 | 51991031214 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-14) |
| 51991-312-33 | 51991031233 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-33) |
| 51991-312-80 | 51991031280 | 80 TABLET, EXTENDED RELEASE in 1 CARTON (51991-312-80) |
| 51991-312-90 | 51991031290 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/25bdfc41-c7cb-4d16-b6a8-f102f9b8c984NADAC price for package 51991031210
GET /v1/drugs/nadac/51991031210NADAC price for package 51991031233
GET /v1/drugs/nadac/51991031233NADAC price for package 51991031290
GET /v1/drugs/nadac/51991031290
Use it
Look up 51991-312 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51991-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51991-312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.